Royce & Associates’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Buy |
2,637,121
+636,618
| +32% | +$764K | 0.03% | 541 |
|
|
2025
Q1 | $2.16M | Buy |
2,000,503
+545,000
| +37% | +$589K | 0.02% | 579 |
|
|
2024
Q4 | $2.55M | Buy |
1,455,503
+840,951
| +137% | +$1.47M | 0.02% | 595 |
|
|
2024
Q3 | $1.19M | Buy |
614,552
+310,321
| +102% | +$599K | 0.01% | 708 |
|
|
2024
Q2 | $538K | Buy |
+304,231
| New | +$538K | 0.01% | 785 |
|
|
2019
Q4 | – | Sell |
-122,400
| Closed | -$567K | – | 1157 |
|
|
2019
Q3 | $567K | Sell |
122,400
-63,000
| -34% | -$292K | 0.01% | 881 |
|
|
2019
Q2 | $2.28M | Hold |
185,400
| – | – | 0.02% | 695 |
|
|
2019
Q1 | $2.46M | Buy |
185,400
+37,000
| +25% | +$492K | 0.02% | 681 |
|
|
2018
Q4 | $1.28M | Buy |
+148,400
| New | +$1.28M | 0.01% | 824 |
|
|
2013
Q4 | – | Sell |
-3,300
| Closed | -$72K | – | 1458 |
|
|
2013
Q3 | $72K | Hold |
3,300
| – | – | ﹤0.01% | 1378 |
|
|
2013
Q2 | $58K | Buy |
+3,300
| New | +$58K | ﹤0.01% | 1368 |
|